| Literature DB >> 24307243 |
Veronica Santarlasci1, Laura Maggi, Alessio Mazzoni, Manuela Capone, Valentina Querci, Maria Caterina Rossi, Luca Beltrame, Duccio Cavalieri, Raffaele De Palma, Francesco Liotta, Lorenzo Cosmi, Enrico Maggi, Sergio Romagnani, Francesco Annunziato.
Abstract
Human Th17 cells have a limited proliferative capacity compared to other T-cell subsets. We have shown that human Th17 cells display impaired IL-2 production due to IL-4-induced gene 1 (IL4I1) upregulation. Here, we show that in human Th17 cells, IL4I1 also maintains high levels of Tob1, a member of the Tob/BTG (B-cell traslocation gene) antiproliferative protein family, which prevents cell-cycle progression mediated by TCR stimulation. Indeed, Th17 cells exhibited higher levels of Tob1 than Th1 cells in both resting and TCR-activated conditions. Accordingly, the expression of positive regulators of the cell cycle (cyclin A, B, C, and E and Cdk2), as well as of Skp2, which promotes Tob1 degradation, was lower in Th17 cells than in Th1 cells. Tob1 expression in human Th17 cells correlated with both RAR (retinoic acid receptor)-related orphan receptor C (RORC) and IL4I1 levels. However, RORC was not directly involved in the regulation of Tob1 expression, whereas IL4I1 silencing in Th17 cells induced a substantial decrease of Tob1 expression. These data suggest that IL4I1 upregulation in human Th17 cells limits their TCR-mediated expansion not only by blocking the molecular pathway involved in the activation of the IL-2 promoter, but also by maintaining high levels of Tob1, which impairs entry into the cell cycle.Entities:
Keywords: Human Th17 cells; IL4I1; T cell cycle; Tob1
Mesh:
Substances:
Year: 2013 PMID: 24307243 DOI: 10.1002/eji.201344047
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532